Curcumin improves mood in depression
Dr. Adrian Lopresti, who works at the Faculty of Psychology of Murdoch University, studied the effects of curcumin - the active substances of plant origin. The study was conducted with the participation of 56 volunteers who have been diagnosed with clinical depression. Half of the subjects received a proprietary extract of curcumin (500 mg twice daily) and half - placebo. The study lasted 8 weeks.
Starting from the fourth week of the trial doctor Lopresti found in volunteers treated with curcumin, a significant reduction of the negative symptoms associated with mood, while those who received placebo, these effects were not observed. The maximum efficiency of the active substance was found in people with atypical depression, which is characterized by obesity, increased appetite, and drowsiness.
"In the experiments carried out on animals, curcumin repeatedly demonstrated antidepressant properties, and therefore it was assumed that curcumin will also have antidepressant properties for people with clinical depression," - said Dr. Lopresti, who also has a private practice as a clinical psychologist.
"Our findings support studies have established a link between depression and inflammatory processes. Contrary to what was previously thought, depression is associated not only with the brain chemicals like serotonin. This is confirmed by the fact that we saw particularly good results in the group of volunteers with atypical depression, with where there is an increased level of proteins, harmful effects on the body, "- said the scientist.
Beneficial effect of curcumin molecules on the body is studied by scientists around the world for a long time. However, until recently it was not possible to solve the problem of delivering the drug to the cells - curcumin, getting into the body, quickly neutralized by the liver enzymes and the conclusion is almost no time to have effect. The problem of transporting curcumin decided Research Laboratory, which is part of the corporation Sabinsa (USA). It has developed a unique formula, made up, in addition to curcumin, including two of its chemical derivatives, as well as a patented ingredient Bioperine. Therapeutic effect created based on the formula of the preparation was confirmed in more than 80 publications and 45 clinical trials.
Starting from the fourth week of the trial doctor Lopresti found in volunteers treated with curcumin, a significant reduction of the negative symptoms associated with mood, while those who received placebo, these effects were not observed. The maximum efficiency of the active substance was found in people with atypical depression, which is characterized by obesity, increased appetite, and drowsiness.
"In the experiments carried out on animals, curcumin repeatedly demonstrated antidepressant properties, and therefore it was assumed that curcumin will also have antidepressant properties for people with clinical depression," - said Dr. Lopresti, who also has a private practice as a clinical psychologist.
"Our findings support studies have established a link between depression and inflammatory processes. Contrary to what was previously thought, depression is associated not only with the brain chemicals like serotonin. This is confirmed by the fact that we saw particularly good results in the group of volunteers with atypical depression, with where there is an increased level of proteins, harmful effects on the body, "- said the scientist.
Beneficial effect of curcumin molecules on the body is studied by scientists around the world for a long time. However, until recently it was not possible to solve the problem of delivering the drug to the cells - curcumin, getting into the body, quickly neutralized by the liver enzymes and the conclusion is almost no time to have effect. The problem of transporting curcumin decided Research Laboratory, which is part of the corporation Sabinsa (USA). It has developed a unique formula, made up, in addition to curcumin, including two of its chemical derivatives, as well as a patented ingredient Bioperine. Therapeutic effect created based on the formula of the preparation was confirmed in more than 80 publications and 45 clinical trials.